Dr. Guillermo Ulises Ruiz-Esparza

Shortcuts

• Address
• Alerts
• Claim ownership or report listing
• 

  Want your practice to be the top-listed Clinic in Boston?

Biography

Dr. Guillermo Ulises Ruiz-Esparza is a Medical Doctor and BioNanotechnologist. He received his MD and PhD in Nanomedicine from the Houston Methodist Hospital - Monterrey Institute of Technology and Higher Education Joint MD/PhD Program, later on he pursued his Postdoctoral training in Molecular Nanomedicine at Harvard University, Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital. His research is mainly focused in the development of Molecular NanoSystems at the Harvard-MIT Division of Health Sciences and Technology and at the Division of Engineering in Medicine part of Brigham and Women's Hospital and Harvard Medical School. He is a pioneer in the field of cardiovascular nanomedicine, as his work was the first to achieve intravascular and site-specific nanoparticle-based delivery to a failing heart, enabling the current development of new nanotechnologies for delivering genetic material and drugs for the treatment of heart failure. He has also developed pioneering nanotechnologies for spatiotemporal and sequential release of dual therapeutic agents within the same nanosystem as published in the cover of the prestigious scientific journal "Advanced Functional Materials". As an example of the quality of his work, Massachusetts Institute of Technology (MIT) – Technology Review recognized him with the prestigious TR35 award as one of the world's top innovators under the age of 35, and more recently, he received the Harvard Pilgrim Health Care Institute – Healthcare Award and the Future of Health Technology Award at the MIT Media Lab. He has been named one of the 30 most influential Latino leaders in the US under the age of 30 by El Mundo Boston and one of the most promising Mexican individuals under the age of 40 by CNN Expansion. Singularity University from Silicon Valley in association with CDI and Poder Civico recognized him with the “Gifted Citizen Award”, as one of the emerging global innovators with projects aimed to impact more than 10 million people in the next years. Recently, he was the recipient of the National Youth Award in Science and Technology bestowed by the President of Mexico Enrique Peña Nieto, the highest honor and state decoration that the Mexican government can bestow on young physicians and researchers that live in Mexico or abroad. He also has been distinguished as Fellow and Member of the Royal Society of Arts in United Kingdom, one of the oldest and most prestigious and exclusive royal academic societies in the world, and has been invited to meet with the Prince Charles of Wales to discuss about medical innovation and social entrepreneurship in Mexico. At his young age, Guillermo has numerous publications in high impact scientific journals such as “Science Translational Medicine”, “Advanced Materials”, “Advanced Functional Materials”, “European Journal of Heart Failure”, “Materials Science and Engineering: R: Reports”, to name a few, and the quality of his nanotechnology innovations has been recognized with several journal covers and has been featured in hundreds of media coverage worldwide. His pioneering work has been presented in some of the most prestigious forums and congresses around the world, such as Harvard University, the American College of Cardiology Annual Meeting, the European Society of Cardiology, the World Congress of Acute Heart Failure, Heart Failure Society of America, EmTech by Massachusetts Institute of Technology (MIT) – Technology Review, Future Health Technology Annual Conference at MIT and others. Guillermo is also involved in social causes and has received several awards in Social Leadership by Tecnologico de Monterrey for the creation of educational programs in science and technology for underserved communities in Mexico. His main interests are innovation, technology, science, medicine, entrepreneurship, public health policy, education and social causes.